PhytoHealth Corp. was founded in November 1998 and was listed in OTC as emerging stocks. PhytoHealth is principally engaged in the research, development and licensing of western drugs, cosmetics and healthcare products. The company operates its businesses through the development of new drugs, which provides PHN011, PHN012, PHN013, PHN031, PHN081, PHN121 and PHN131 for the treatment of car sick, sea sick, air sick, marrow depression, osteoporosis and cough, as well as healthcare food business, drug supply for public hospitals, agent import and export trading of Chinese patent medicines and materials. The company distributes its products in domestic and overseas markets, with Taiwan as its major market.
Headquarters
Fl.5-1,No.167, Fu Hsing N. Rd.
Taipei City; Taipei City;
Contact Details: Purchase the Phytohealth Corporation report to view the information.
Website: http://www.phytohealth.com.tw
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service